US Patent 11229633 Arimoclomol formulation
Patent 11229633 was granted and assigned to Orphazyme on January, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 23, 2020
Date of Patent
January 25, 2022
Patent Applicant
Patent Application Number
16826733
Patent Inventor Names
Thomas Kirkegaard Jensen
0
Anders Mørkeberg Hinsby
0
Carlos Roberto Camozzi
0
Gert Mads Bolwig
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11229633 Arimoclomol formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.